acrolein has been researched along with Diabetes Mellitus, Type 1 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, M; Liu, R; Wang, L; Wu, H; Zhang, K; Zhao, H; Zhu, Q | 1 |
| Beppu, M; Hata, I; Hiraoka, M; Kaji, M; Kawakami, H; Mayumi, M; Momoi, T; Sekine, K; Todoroki, Y; Tsukahara, H; Uchiyama, M; Yorifuji, T; Yoshihara, K | 1 |
2 other study(ies) available for acrolein and Diabetes Mellitus, Type 1
| Article | Year |
|---|---|
Cinnamaldehyde Improves Metabolic Functions in Streptozotocin-Induced Diabetic Mice by Regulating Gut Microbiota.
Topics: Acrolein; Animals; Diabetes Mellitus, Experimental; Diabetes Mellitus, Type 1; Gastrointestinal Microbiome; Male; Mice; Mice, Inbred C57BL; Streptozocin | 2021 |
Formation of advanced glycosylation end products and oxidative stress in young patients with type 1 diabetes.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acrolein; Adolescent; Adult; Arginine; Child; Child, Preschool; Creatinine; Deoxyguanosine; Diabetes Mellitus, Type 1; Female; Glycation End Products, Advanced; Humans; Lysine; Male; Norleucine; Oxidative Stress; Pyrroles; Regression Analysis | 2003 |